MetLife Investment Management’s Oak Street Health, Inc. OSH Stock Holding History

MetLife Investment Management’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,412	Closed	-$93.3K	–	3030
2023 Q1	$93.3K	Buy	2,412 +5	+0.2%	+$161	﹤0.01%	2579
2022 Q4	$51.8K	Buy	2,407 +12	+0.5%	+$251	﹤0.01%	2756
2022 Q3	$58.7K	Sell	2,395 -58	-2%	-$1.53K	﹤0.01%	2752
2022 Q2	$40.3K	Sell	2,453 -3,471	-59%	-$67.4K	﹤0.01%	2818
2022 Q1	$159K	Buy	+5,924	New	+$125K	﹤0.01%	2485

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

MetLife Investment Management's OSH Position: Q2 2023 in Review

MetLife Investment Management sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 2,412 shares — an estimated $93.3K sold.

MetLife Investment Management first reported a position in OSH in Q1 2022 and held it in 5 quarters. The position peaked at $159K in Q1 2022. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

MetLife Investment Management reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
MetLife Investment Management sold 2,412 Oak Street Health, Inc. shares in Q2 2023, an estimated $93.3K.
MetLife Investment Management first reported a position in Oak Street Health, Inc. in Q1 2022 and held it in 5 quarters.
MetLife Investment Management's Oak Street Health, Inc. position peaked at $159K in Q1 2022.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.